Simvastatin inhibits the expression of 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMGCR), downregulating the mevalonate pathway and GPX4, thereby inducing ferroptosis in cancer cells [59]. Here, HMGCR is linked to cancer.